FDA inspection
Aft Pharmaceuticals Limited: FDA inspection ending Oct 20, 2023
FDA inspection 1222051 · No Action Indicated (NAI) · Auckland
Key facts
| Inspection ID | 1222051 |
|---|---|
| Firm | Aft Pharmaceuticals Limited |
| FEI number | 3011756349 |
| Address | Level 1, 129 Hurstmere Road; Takapuna |
| City | Auckland |
| Country | New Zealand |
| Fiscal year | 2024 |
| Inspection end date | Oct 20, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data